Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
70,886,873
-
Total 13F shares
-
55,176,587
-
Share change
-
+1,494,944
-
Total reported value
-
$2,185,676,412
-
Put/Call ratio
-
58%
-
Price per share
-
$39.62
-
Number of holders
-
176
-
Value change
-
+$48,584,354
-
Number of buys
-
88
-
Number of sells
-
90
Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q4 2021
As of 31 Dec 2021,
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,176,587 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, ALLIANCEBERNSTEIN L.P., Clearbridge Investments, LLC, JANUS HENDERSON GROUP PLC, RIVERBRIDGE PARTNERS LLC, and abrdn plc.
This page lists
177
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.